Donor lymphocytes labeled with in-vitro bispecific antibodies
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor lymphocytes labeled with in-vitro bispecific antibodies, covering 2011-04-08 to 2011-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies. [Phase 2]